▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | Italian Channel Awards | Italian Project Awards | Italian Security Awards | ...
InnovationOpenLab

L7 Informatics and Turnberry Solutions Announce Strategic Teaming Agreement to Accelerate Life Sciences Innovation at Enterprise Scale

L7 Informatics, Inc., and Turnberry Solutions, Inc. today announced the completion of a strategic Teaming Agreement, establishing a formal collaboration to jointly pursue enterprise digital transforma...

Immagine

Collaboration combines AI-ready data platforms with delivery certainty to help life sciences and food companies move faster-from strategy to measurable outcomes.

AUSTIN, Texas & MINNEAPOLIS: L7 Informatics, Inc., and Turnberry Solutions, Inc. today announced the completion of a strategic Teaming Agreement, establishing a formal collaboration to jointly pursue enterprise digital transformation initiatives across the life sciences and food industries. The partnership is designed to help organizations accelerate innovation, modernize operations, and achieve measurable business outcomes, while maintaining speed, scale, and execution certainty.

Life sciences enterprises are under mounting pressure to move faster while navigating fragmented data environments, complex regulatory requirements, and growing expectations around AI adoption. Yet many struggle to find partners who can pair strategic vision with real-world execution velocity. Clients are increasingly demanding speed, scale, and substance, and this teaming agreement is purpose-built to deliver exactly that.

By combining L7 Informatics’ unified, AI-ready data platform (L7|ESP) with Turnberry’s business-outcome-first, cloud-exclusive digital services model, the two companies will provide clients with an integrated path from data foundation to enterprise impact. Together, they will support large, multi-site implementations, predictable deployments, and faster time-to-value across research, development, and manufacturing environments.

“Life sciences organizations don’t need more disconnected tools or abstract roadmaps; they need a unified platform and a partner who can execute with precision,” said Mark Spencer, President & CEO of L7 Informatics. “Turnberry brings a rare combination of delivery certainty, deep life sciences expertise, and enterprise-scale execution. This partnership strengthens our ability to help customers eliminate data silos, become truly AI-ready, and turn scientific data into operational and clinical advantage.”

L7 Informatics’ L7|ESP platform replaces fragmented LIMS, ELN, MES, and scheduling systems with a single, ontology-driven solution that contextualizes data at the point of capture and orchestrates end-to-end workflows. The result is a unified, AI-ready data foundation that accelerates drug development, reduces operational friction, and enables advanced analytics and machine learning, without requiring a disruptive rip-and-replace of existing systems.

Turnberry Solutions redefines digital services through a delivery-certainty-driven approach that combines boutique agility with global scale. Serving seven of the world’s top ten pharmaceutical companies, Turnberry helps life sciences organizations advance patient outcomes through simplification, optimization, digital health, advanced AI, and regulatory-aware transformation.

“Our clients expect outcomes, not experiments,” said Bill Ravenscroft, CEO of Turnberry Solutions. “L7’s platform solves one of the hardest problems in life sciences, creating a true unified, contextualized data that works at enterprise scale. Together, we can move clients from ambition to execution faster, with the confidence that what we design can be delivered, scaled, and sustained.”

The Teaming Agreement reinforces L7 Informatics’ collaborative partner model, enabling certified partners to design, configure, and implement L7|ESP to meet exacting scientific and operational requirements. For customers, the partnership delivers faster deployments, predictable results, stronger pre-sales alignment, and broader access to enterprise transformation initiatives.

As life sciences organizations race to modernize and operationalize AI, L7 Informatics and Turnberry Solutions are positioning themselves as a powerful alliance, one that unites platform innovation with execution excellence to help clients move faster, smarter, and with confidence.

About L7 Informatics

L7 Informatics provides a unified digital platform that eliminates data silos across pharmaceutical, biotech, CDMO, diagnostics, and research organizations. Its L7|ESP platform contextualizes data at the source and orchestrates workflows across research, development, and manufacturing, creating an AI-ready foundation for enterprise-scale innovation. L7 has been recognized by Frost & Sullivan as the Global Leader in Innovation for Pharmaceutical and Biotech LIMS and has appeared on the Deloitte Technology Fast 500 for four consecutive years.

About Turnberry Solutions

Turnberry Solutions is a global digital services company that helps organizations achieve measurable business outcomes through a cloud-exclusive, delivery-certainty-driven model. With deep expertise in life sciences, Turnberry partners with leading enterprises to simplify complexity, accelerate innovation, and deliver transformation at scale.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

RSA at Cybertech Europe 2024

Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…

Italian Security Awards 2024: G11 Media honours the best of Italian cybersecurity

G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes

How Austria is making its AI ecosystem grow

Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries

Sparkle and Telsy test Quantum Key Distribution in practice

Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…

Most read

Ubicept Showcases Physics-Based Imaging at CES 2026 to Usher in the Next…

Ubicept, the computer vision startup operating at the limits of physics, today announced live demonstrations of the Ubicept Toolkit at CES 2026. The Ubicept…

Verisign to Report Fourth Quarter and Full Year 2025 Financial Results

VeriSign, Inc. (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, today announced that its live…

Calix to Post Fourth Quarter 2025 Results on January 28, 2026

Calix, Inc. (NYSE:CALX) today announced that on Wednesday, January 28, 2026, after market close, the company will post on the Calix Investor Relations…

Atropos Health Appoints Kevin Smith to Chief Growth Officer to Accelerate…

Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence (RWE), today announced the appointment of Kevin…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!